Literature DB >> 11381500

Dissociation between T helper type 1 and type 2 differentiation and cytokine production in tumor-infiltrating lymphocytes in patients with lung cancer.

N Ito1, H Nakamura, H Metsugi, S Ohgi.   

Abstract

We recently reported the balance of T helper type 1 (Th1) cells and type 2 (Th2) cells in patients with lung carcinomas. This study was conducted to investigate their activity and role in tumors, which remain unclear. We determined the population of lymphocytes with intracellular interferon (IFN)-gamma or interleukin (IL)-4 by flow cytometry, and investigated cytokine production using enzyme-linked immunosorbent assay (ELISA) in 22 patients with non-small cell lung cancer. The IFN-gamma-positive subset showed a significant increase in the number of tumor-infiltrating lymphocytes (TIL) compared with the peripheral blood lymphocytes (PBL) (PBL, 13.8% +/- 1.5%; TIL, 34.3% +/- 3.4%; P < 0.001), and the IL-4 positive subset showed reverse results (PBL, 3.7% +/- 0.6%; TIL, 2.1% +/- 0.3%; P = 0.037). However, TIL did not produce more IFN-gamma than PBL. The results of intracellular IFN-gamma analysis and the production of IFN-gamma in PBL and TIL were significantly correlated (PBL: n = 22, r = 0.50, P = 0.025; TIL: n = 22, r = 0.44, P = 0.022). The dissociation between Th1 differentiation and IFN-gamma production in TIL was one of the host factors influencing the immune anergy against tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11381500     DOI: 10.1007/s005950170127

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  6 in total

1.  Tumor-released survivin induces a type-2 t cell response and decreases cytotoxic T cell function, in vitro.

Authors:  Jessica M S Jutzy; Salma Khan; Malyn May Asuncion-Valenzuela; Terry-Ann M Milford; Kimberly J Payne; Nathan R Wall
Journal:  Cancer Microenviron       Date:  2012-02-10

2.  Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.

Authors:  Dajing Xia; Shu Zheng; Weiping Zhang; Long He; Qingqing Wang; Jianping Pan; Lihuang Zhang; Jianli Wang; Xuetao Cao
Journal:  J Mol Med (Berl)       Date:  2003-08-21       Impact factor: 4.599

3.  Intratumoral expression of macrophage migration inhibitory factor is correlated with serum C-reactive protein and interleukin-6 in patients with non-small cell lung cancer.

Authors:  Motoharu Hamatake; Ichiro Yoshino; Makiko Tomiyasu; Naoko Miura; Hiroshi Okazaki; Taro Ohba; Tomohiro Takenaka; Yoshihiko Maehara
Journal:  Surg Today       Date:  2008-09-27       Impact factor: 2.549

4.  Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.

Authors:  Shuguang Zuo; Min Wei; Shiqun Wang; Jie Dong; Jiwu Wei
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

Review 5.  The Molecular Role of IL-35 in Non-Small Cell Lung Cancer.

Authors:  Yuqiu Hao; Hongna Dong; Wei Li; Xuejiao Lv; Bingqing Shi; Peng Gao
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

6.  Clinical significance of serum T helper 1/T helper 2 cytokine shift in patients with non-small cell lung cancer.

Authors:  Jun Li; Zhenhua Wang; Kai Mao; Xixi Guo
Journal:  Oncol Lett       Date:  2014-07-29       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.